Diroximel fumarate is a pharmaceutical raw material used in the manufacturing of active pharmaceutical ingredients for relapsing forms of multiple sclerosis. It is a fumarate compound designed to be bioequivalent to dimethyl fumarate but with a modified chemical structure intended to reduce gastrointestinal side effects.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Diroximel fumarate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
IFN-gamma Antagonist
pharmaceutical raw material
2-(2-Amino-1,3-thiazol-4-yl)-N-(4-(2-((2-phenylethyl)amino)ethyl)phenyl)acetamide
pharmaceutical raw material
Cromolyn sodium
pharmaceutical raw material
Irofulven
pharmaceutical raw material
The international HS code for Diroximel fumarate (CAS 1577222-14-0) is 2925.19.
2925.19
2925 19 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate
YIMYDTCOUQIDMT-SNAWJCMRSA-N
COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O
Sourcing Diroximel fumarate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.